CD163 and colorectal carcinoma: We studied the presence of circulating CD14+ and/or CD163+ monocytes in pre-operative PBMC samples from CRC patients (N = 47) and healthy donors (N = 10) with multiparameter flow cytometry using a standardized gating strategy (Figure S1).